WebJan 26, 2024 · Sierra Oncology Inc. (NASDAQ: SRRA) of San Mateo will use some of the proceeds to prepare for the commercialization of momelotinib, a drug it bought a little more than three years ago from Gilead ... WebApr 13, 2024 · It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Show more Gilead Sciences, Inc. Fundamentals Summary
Sierra Oncology initiates study of momelotinib in myelofibrosis
WebMar 6, 2024 · Vice President, Clinical Development at Sierra Oncology . Jun Kawashima is a Vice President, Clinical Development at Sierra Oncology based in San Mateo, California. Previously, Jun was an Executive Senior Director, Clinical Research Hematology & Oncology at Gilead and also held positions at Kite Pharma, Alcami. Read More WebJan 25, 2024 · Sierra Oncology myelofibrosis drug momelotinib achieved the main and … chlorine and water disproportionation
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial …
WebJun 2, 2011 · 1. Gilead Sciences. @GileadSciences. ·. Gilead is proud to support. @ETAForg. for #HIVIsNotACrime Awareness Day. We are helping dismantle HIV criminalization laws that drive disparities in HIV care and deter testing. elizabethtayloraidsfoundation.org. WebSierra's bet on Gilead castoff pays off, ... President and CEO, will be presenting an overview of Sierra Oncology and the MOMENTUM Phase 3 clinical trial at the Oppenheimer Healthcare Fall Summit. WebAug 17, 2024 · The clock is now ticking on the FDA's review of GSK's momelotinib for myelofibrosis patients with anaemia – the centrepiece of its $1.9 billion acquisition of Sierra Oncology which completed ... grateley to london waterloo